Inhibrx Biosciences, Inc. INBX 深 沪
等待开盘 05-19 09:30:00 美东时间
105.80
-2.840
-2.61%
华盛通- 最 高110.9868
- 今 开108.64
- 成交量 39.38万股
- 最 低 100.41
- 昨 收 108.64
- 总市值 15.52亿
- 52周最高 155.29
- 市盈率 静 --
- 换手率 2.68%
- 52周最低 12.675
- 委 比 -4.76%
- 总股本 1467.12万
- 历史最高 155.29
- 量 比 0.44
- 振 幅 9.74%
- 历史最低 7.67
- 每 手 1
- 风险率 32.78%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Inhibrx Biosciences GAAP EPS of -$2.15
Inhibrx Biosciences press release (INBX): Q1 GAAP EPS of -$2.15. Cash and Cash Equivalents. As of March 31, 2026, the Company had cash and cash equivalents of $161.7 million, as compared to $124.2 mil...
05-15 04:46
Inhibrx Biosciences Q1 EPS $(2.15) Misses $(1.79) Estimate
Inhibrx Biosciences (NASDAQ:INBX) reported quarterly losses of $(2.15) per share which missed the analyst consensus estimate of $(1.79) by 20.11 percent. This is a 23.21 percent increase over losses of $(2.80) per share
05-15 04:38
美股夜盘 | Fundrise Innovation Fund, LLC涨16.13%，奇景光电涨11.30%
Fundrise Innovation Fund, LLC涨16.13%；奇景光电涨11.30%；Inhibrx Biosciences, Inc.涨11.28%
05-11 13:01
美股夜盘 | Inhibrx Biosciences, Inc.涨10.90%，最新股价149.0美元
Inhibrx Biosciences, Inc.涨10.90%，报149.0美元
05-11 11:02
美股夜盘 | Rackspace Technology, Inc.涨16.39%，Fundrise Innovation Fund, LLC涨15.71%
Rackspace Technology, Inc.涨16.39%；Fundrise Innovation Fund, LLC涨15.71%；奇景光电涨14.45%
05-11 10:01
美股夜盘 | Fundrise Innovation Fund, LLC涨15.19%，Rackspace Technology, Inc.涨13.84%
Fundrise Innovation Fund, LLC涨15.19%；Rackspace Technology, Inc.涨13.84%；Penguin Solutions Incorporation涨13.36%
05-11 09:01
Inhibrx Biosciences To Present Interim Phase 2 HexAgon Study Results For INBRX-106 Plus Keytruda In Head And Neck Cancer On May 11, 2026 Webcast
– Event to be webcast live on Monday, May 11, 2026, at 5:30 a.m. PT –SAN DIEGO, May 8, 2026 /PRNewswire/ -- Inhibrx Biosciences, Inc. (NASDAQ:INBX) ("Inhibrx" or the "Company"), a clinical-stage biopharmaceutical company
05-09 04:01
Pfizer Says Cancer Therapy Beats Standard Therapy In Late-Stage Blood Cancer Study
Pfizer reports Phase 3 data showing ELREXFIO improved progression-free survival versus standard therapy in multiple myeloma study.
04-30 02:41
Adagio Medical Heart Ablation System Shows 84% Freedom From Shock
Adagio Medical shares rise after vCLAS trial shows strong VT outcomes, reduced drug use, and lower readmissions ahead of FDA review.
04-27 19:55
美股周涨跌榜 | 费城半导体指数18连涨！MaxLinear周内暴涨130%，ARM狂飙逾40%
费城半导体指数18连涨！MaxLinear周内暴涨130%；英特尔炸裂财报点燃CUP概念行情，ARM周内狂飙逾40%，AMD大涨25%>>
04-25 10:13
